课题基金 / 基金详情

项目摘要

项目成果

John T Belisle的其他基金

相似基金

相关文献

中文摘要
翻译
RMRCE的战略计划是基于该项目过去的成功,以及那些在许多方面表现出真实的、独特的RMRCE优势的活动。这些包括:1)在未充分研究的病原体,特别是伯克霍尔德氏菌和科西埃氏菌方面建立国内和国际公认的专业知识和研究能力;2)在整个地区利用新的BSL3能力,包括落基山地区生物控制实验室;3)只研究毒性选择剂而不是模式生物;4)开发治疗方法和疫苗的广泛平台技术;这包括最初由科罗拉多州立大学开发的阳离子脂质DMA复合物(CLDC),它将被细菌利用
英文摘要
The strategic plan for the RMRCE is based on the program's past successes and those activities that have emerged as true and in many ways unique RMRCE strengths. These include: 1) establishment of nationally and internationally recognized expertise and research capabilities in understudied pathogens, especially Burkholderia and Coxiella; 2) utilization of new BSL3 capabilities across the region, including the Rocky Mountain Regional Biocontainment Laboratory, 3) studies of only virulent Select Agents instead of model organisms; 4) development of broad-platform technologies for therapeutics and vaccines; this includes cationic lipid DMA complex (CLDC) originally developed at Colorado State University which will be used by bacterial and viral research projects alike; 5) highly integrated research projects; and 6) institution of region wide RMRCE leadership. These are the strengths and opportunities that the RMRCE will build on for the next 5 years. Additionally, the strategic plan takes into account NIAID mandated RCE activities that are in need of restructuring and refocusing under the RMRCE. Based on programmatic strengths the overall RMRCE structure (Figure 1) was developed to emphasize a robust and flexible research program that is directed at specific thematic areas important to the overall national effort in biodefense and emerging infectious diseases research, and that is supported by scientific cores designed to enhance research and facilitate product development. This structure and strategic plan also are aligned with the previously stated goals of this program. The details of the operation of the RMRCE and the individual components are described in the Action Plan (Section A-2.4) and the strengths and opportunities enabling this organizational structure are detailed in Sections A-2.1 and A-2.2. The thematic areas that from the basis of the RMRCE strategic plan are discussed in section A- 2.3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
  • 批准号:
    10197000
  • 项目类别:
  • 资助金额:
    $150.0万
  • 财政年份:
    2020
  • 负责人:
    John T Belisle
  • 依托单位:
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
  • 批准号:
    10418673
  • 项目类别:
  • 资助金额:
    $150.0万
  • 财政年份:
    2020
  • 负责人:
    John T Belisle
  • 依托单位:
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
  • 批准号:
    9981167
  • 项目类别:
  • 资助金额:
    $150.0万
  • 财政年份:
    2020
  • 负责人:
    John T Belisle
  • 依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
  • 批准号:
    10409724
  • 项目类别:
  • 资助金额:
    $75.23万
  • 财政年份:
    2019
  • 负责人:
    John T Belisle
  • 依托单位:
海外基金